THESEUS PHARMACEUTICALS INC's ticker is and the CUSIP is 88369M101. A total of 64 filers reported holding THESEUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Red Tortoise LLC | 536 | $1,442 | 0.00% |
TD ASSET MANAGEMENT INC | 213,896 | $575,380 | 0.00% |
Renaissance Technologies | 126,194 | $339 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
MANUFACTURERS LIFE INSURANCE COMPANY, THE | 79,751 | $214,530 | 0.00% |
Legal & General Group Plc | 1,930 | $5,192 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 405,578 | $1,091,124 | 0.00% |
STATE STREET CORP | 368,660 | $991,695 | 0.00% |
PRICE T ROWE ASSOCIATES INC /MD/ | 1,216,500 | $3,273 | 0.00% |
NEW YORK STATE COMMON RETIREMENT FUND | 9,606 | $26 | 0.00% |
STRS OHIO | 2,700 | $7 | 0.00% |
DEUTSCHE BANK AG\ | 870 | $2,340 | 0.00% |
CITIGROUP INC | 15 | $40 | 0.00% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 56,203 | $151,186 | 0.00% |
MORGAN STANLEY | 38,570 | $103,753 | 0.00% |
AMALGAMATED BANK | 1,796 | $5 | 0.00% |
BlackRock Inc. | 1,340,480 | $3,605,891 | 0.00% |
Bank of New York Mellon Corp | 59,553 | $160,198 | 0.00% |
Nuveen Asset Management, LLC | 81,898 | $779,668 | 0.00% |
TWO SIGMA ADVISERS, LP | 12,200 | $32,818 | 0.00% |
This page lists THESEUS PHARMACEUTICALS INC's shareholders in Q3 2023. To view THESEUS PHARMACEUTICALS INC's shareholder history, click here.